Imiquimod

Kathryn Dzintars, Pharm.D., BCPS, Paul G. Auwaerter, M.D., Alice Jenh Hsu, Pharm.D.

INDICATIONS

FDA

  • Condyloma acuminatum
  • Actinic keratoses in immunocompetent adults (typical, nonhyperkeratotic, nonhypertrophic)
  • Primary superficial basal cell carcinoma in immunocompetent adults

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: November 9, 2022